BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.090
+0.050 (1.64%)
Feb 4, 2026, 10:59 AM EST - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $13.56 million as of February 4, 2026. Its market cap has decreased by -54.96% in one year.
Market Cap
13.56M
Enterprise Value
-1.31M
1-Year Change
-54.96%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $13.56M, a decrease of -59.90%. That is a compound annual growth rate of -5.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 13.56M | 3.45% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OSR Holdings | 14.71M |
| Cadrenal Therapeutics | 14.52M |
| Allarity Therapeutics | 14.25M |
| Kairos Pharma | 13.74M |
| KALA BIO | 13.29M |
| Cocrystal Pharma | 13.24M |
| Cellectar Biosciences | 13.23M |
| Hoth Therapeutics | 13.01M |